| P2093 | author name string | Ian M Hastings | |
| | Eline L Korenromp | |
| | Peter B Bloland | |
| P2860 | cites work | Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. | Q46833947 |
| | Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance | Q46878245 |
| | Malaria and mortality: some epidemiological considerations | Q47832249 |
| | Decline of infant and child mortality rates in rural Senegal over a 37-year period (1963-1999). | Q47898776 |
| | Impact of chloroquine resistance on malaria mortality. | Q54121783 |
| | A single amino acid residue can determine the sensitivity of SERCAs to artemisinins | Q22061863 |
| | Modelling a predictable disaster: the rise and spread of drug-resistantmalaria | Q33971977 |
| | Chloroquine-resistant malaria | Q34087800 |
| | Plasmodium chloroquine resistance and the search for a replacement antimalarial drug | Q34153077 |
| | Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience | Q34434822 |
| | Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? | Q34470236 |
| | The assessment of antimalarial drug efficacy | Q34960538 |
| | Malaria drug-sensitivity testing: new assays, new perspectives | Q35104740 |
| | Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy | Q35143090 |
| | Why do some African children develop severe malaria? | Q35907971 |
| | Tolerance is the key to understanding antimalarial drug resistance. | Q36365898 |
| | The burden of malaria mortality among African children in the year 2000. | Q36409519 |
| | Unstable malaria in Sudan: the influence of the dry season. Clone multiplicity of Plasmodium falciparum infections in individuals exposed to variable levels of disease transmission | Q38880269 |
| | Parasitology. A requiem for chloroquine | Q39055410 |
| | Averting a malaria disaster | Q39118502 |
| | Usefulness of clinical case-definitions in guiding therapy for African children with malaria or pneumonia | Q39388619 |
| | Antifolate antimalarial resistance in southeast Africa: a population-based analysis | Q39408064 |
| | An immigration-death model to estimate the duration of malaria infection when detectability of the parasite is imperfect | Q39426350 |
| | The problem of malaria and malaria control in pregnancy in sub-Saharan Africa | Q39489380 |
| | Childhood mortality and probable causes of death using verbal autopsy in Niakhar, Senegal, 1989-2000. | Q40519973 |
| | Response of children with Plasmodium falciparum to chloroquine and development of a national malaria treatment policy in Zaire | Q40790743 |
| | Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa | Q40801749 |
| | A community perspective on the efficacy of malaria treatment options for children in Lundazi district, Zambia | Q41922732 |
| | Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa | Q41925846 |
| | Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa | Q41937986 |
| | Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial | Q44185167 |
| | A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites | Q44495547 |
| | Novel plasmodium falciparum clones and rising clone multiplicities are associated with the increase in malaria morbidity in Ghanaian children during the transition into the high transmission season | Q45041501 |
| | In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). | Q45270651 |
| | Artemisinin resistance: how can we find it? | Q46620546 |
| | Coartem (artemether-lumefantrine) in Africa: the beginning of the end? | Q46681966 |
| | Are we losing artemisinin combination therapy already? | Q46833938 |
| P433 | issue | 11 | |
| P921 | main subject | malaria | Q12156 |
| P304 | page(s) | 739-748 | |
| P577 | publication date | 2007-09-19 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | The anatomy of a malaria disaster: drug policy choice and mortality in African children | |
| P478 | volume | 7 | |